{"id":29514,"date":"2024-12-19T11:08:44","date_gmt":"2024-12-19T16:08:44","guid":{"rendered":"https:\/\/myeloma.ca\/?p=29514"},"modified":"2025-08-19T08:28:07","modified_gmt":"2025-08-19T13:28:07","slug":"ii-recommandations-pour-lutilisation-efficace-des-therapies-de-reorientation-ciblant-lactivation-des-lymphocytes-t-etablissement-dun-consensus-canadien","status":"publish","type":"post","link":"https:\/\/myeloma.ca\/fr\/2024\/12\/19\/ii-recommandations-pour-lutilisation-efficace-des-therapies-de-reorientation-ciblant-lactivation-des-lymphocytes-t-etablissement-dun-consensus-canadien\/","title":{"rendered":"II &#8211; Recommandations pour l&rsquo;utilisation efficace des th\u00e9rapies de r\u00e9orientation ciblant l\u2019activation des lymphocytes T : \u00e9tablissement d\u2019un consensus canadien\u00a0\u00a0"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Auteurs : Guido Lancman, Kevin Song, Darrell White, Tina Crosbie, Ismail Sharif, Marianne Emond, Muhammad Saleem Raza, Martine Elias, Rayan Kaedbey et Michael P. Chu\u00a0<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u00ab\u00a0Nous pr\u00e9sentons ici un ensemble de recommandations visant \u00e0 optimiser l&rsquo;utilisation de la th\u00e9rapie de r\u00e9orientation ciblant l\u2019activation des lymphocytes T dans un contexte canadien. Cet ensemble de recommandations, qui \u00e9voluera dans le temps, comprend des strat\u00e9gies visant \u00e0 am\u00e9liorer et \u00e0 optimiser les voies d&rsquo;acc\u00e8s et corridors de services, la coordination des soins, la s\u00e9lection des patients, la prise de d\u00e9cision clinique et la gestion des \u00e9v\u00e9nements ind\u00e9sirables. La mise en \u0153uvre de ces protocoles devrait permettre de r\u00e8glementer l&rsquo;utilisation des ressources de soins de sant\u00e9, d&rsquo;\u00e9largir l&rsquo;acc\u00e8s aux th\u00e9rapies de r\u00e9orientation ciblant l\u2019activation des lymphocytes T et d&rsquo;am\u00e9liorer les r\u00e9sultats pour les patients atteints de MMRR au Canada, pour les patients, tout en assurant leur s\u00e9curit\u00e9.\u00a0\u00bb<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.frontiersin.org\/journals\/oncology\/articles\/10.3389\/fonc.2024.1446995\/full?utm_source=F-NTF&amp;utm_medium=EMLX&amp;utm_campaign=PRD_FEOPS_20170000_ARTICLE\" target=\"_blank\" rel=\"noreferrer noopener\"><strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-red-color\">Cliquez ici pour en savoir plus<\/mark><\/strong><\/a> (en anglais).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Auteurs : Guido Lancman, Kevin Song, Darrell White, Tina Crosbie, Ismail Sharif, Marianne Emond, Muhammad Saleem Raza, Martine Elias, Rayan Kaedbey et Michael P. Chu\u00a0 \u00ab\u00a0Nous pr\u00e9sentons ici un ensemble de recommandations visant \u00e0 optimiser l&rsquo;utilisation de la th\u00e9rapie de r\u00e9orientation ciblant l\u2019activation des lymphocytes T dans un contexte canadien. Cet ensemble de recommandations, qui [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[58],"tags":[],"class_list":["post-29514","post","type-post","status-publish","format-standard","hentry","category-nouvelles-de-myelome-canada"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/29514","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/comments?post=29514"}],"version-history":[{"count":1,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/29514\/revisions"}],"predecessor-version":[{"id":29515,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/29514\/revisions\/29515"}],"wp:attachment":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/media?parent=29514"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/categories?post=29514"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/tags?post=29514"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}